Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Bionor Pharma ASA
DescriptionInfluenza vaccine comprised of synthetic modified peptides of the conserved regions on the influenza virus
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationInfluenza virus
Indication DetailsVaccinate against influenza virus
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today